SGMC studies cancer drug - WALB.com, Albany News, Weather, Sports

SGMC studies cancer drug

August 31, 2006

Valdosta - Studies indicate one out of six men run the risk of developing prostate cancer.

Doctors at South Georgia Medical Center in Valdosta are beginning a new study they hope will help these cancer patients.  The study is for men who have failed initial treatments after being diagnosed with prostate cancer and must move on to chemotherapy.

They hope the new drug, DN-101, combined with their regular treatments, will make the chemotherapy process easier to handle.  "They are adding an experimental drug which is basically an oral pill that has been shown to have better response rates with prostate cancer and actually allow men to tolerate kemotheropy better. So they had better outcomes and were able to tolerate treatments better," said Medical Oncologist, Dr. Eric Anderson.

The Pearlman Cancer Center at South Georgia Medical Center welcomes any men over the age of 18 who have prostate cancer and failed hormone treatments to participate in the study.

Feedback: news@walb.com?subject=ProstateResearch/Eakin

Powered by WorldNow